✦ LIBER ✦

Effect of Angiotensin Converting Enzyme Inhibitor or Beta-Blocker Use on the Benefit of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial

✍ Scribed by Jalal K. Ghali; Anne L. Taylor; S. William Tam; Michael L. Sabolinski; Manuel Worcel; Jay N. Cohn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Fixed-Dose Combined Isosorbide

✍ Anne L. Taylor; Michael L. Sabolinski; S. William Tam; Susan Ziesche; Jalal K. G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Influence of Blood Pressure on the Effec

✍ Inder S. Anand; S. William Tam; Thomas S. Rector; Anne L. Taylor; Michael L. Sab 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 811 KB

In-Trial Economic Evaluation of a Fixed-

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 24 KB

GNB3 TT Genotype Predicts Enhanced Benef

✍ Dennis M. McNamara; S. William Tam; Michael L. Sabolinski; Page Tobelmann; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 78 KB